Carbon monoxide (CO) is a known endogenous signaling molecule with potential
therapeutic indications in treating inflammation, cancer, neuroprotection, and sickle cell …

A novel orally bioavailable solid formulation to deliver a gaseous signaling molecule, carbon
monoxide (CO), was developed by adsorbing oxalyl saccharin, a newly developed organic …

Carbon monoxide is an important gasotransmitter in mammals, with pleiotropic therapeutic
potential against a wide range of human diseases. However, clinical translation of CO is …

As one of the three known gasotransmitters, carbon monoxide (CO) has demonstrated
therapeutic potential against a wide range of human diseases. However, development of CO …

The use of Carbon Monoxide (CO) as a therapeutic agent has already been tested in human
clinical trials. Pre-clinically, CO gas administration proved beneficial in animal models of …

Carbon monoxide (CO) is an intrinsic signaling molecule with importance on par with that of
nitric oxide. During the past decade, pharmacologic studies have amply demonstrated the …

Carbon monoxide (CO) is an endogenously produced gasotransmitter in mammals, and
may have signaling roles in bacteria as well. It has many recognized therapeutic effects. A …

Along with the impressive achievements in understanding the endogenous signaling roles
and mechanism (s) of action of carbon monoxide (CO), much research has demonstrated …

Carbon monoxide (CO), an endogenous signaling molecule, is known to exert a range of
pharmacological effects, including anti-inflammation, organ protection, and antimetastasis in …

Carbon monoxide belongs to the family of signaling molecules and has been shown to
possess therapeutic effects. Similar to NO, safe delivery of CO is a key issue in developing …